This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Medical Properties (MPW) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Medical Properties (MPW) closed at $22.11, marking a +0.41% move from the previous day.
Medical Properties (MPW) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Medical Properties (MPW) closed the most recent trading day at $21.84, moving -0.46% from the previous trading session.
Medical Properties (MPW) Q3 FFO Match Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 0.00% and 1.19%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Key Factors to Impact Medical Properties' (MPW) Q3 Earnings
by Zacks Equity Research
Stellar revenues from transactions and improving fundamentals of its tenants are likely to have aided Medical Properties' (MPW) Q3 performance.
HCA Healthcare (HCA) to Acquire Facilities in Utah From Steward
by Zacks Equity Research
HCA Healthcare (HCA) to buy five Utah hospitals from Steward to expand its dominance in the region, and provide cost-effective and enhanced healthcare to patients.
Is Medical Properties Trust (MPW) a Good Pick for Value Investors?
by Zacks Equity Research
Is Medical Properties Trust (MPW) a great pick from the value investor's perspective right now? Read on to know more.
Zacks.com featured highlights include: Walmart, Vertex Pharma, Medical Properties Trust, TriNet Group and TriMas Corp
by Zacks Equity Research
Zacks.com featured highlights include: Walmart, Vertex Pharma, Medical Properties Trust, TriNet Group and TriMas Corp
Rising P/E: A Trick to Land on 5 Winning Stocks
by Sanghamitra Saha
Want to try a different approach? Tap five stocks with increasing P/E ratios.
Medical Properties (MPW) Q2 FFO Match Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 0.00% and 3.42%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Medical Properties Trust (MPW) This Earnings Season?
by Zacks Equity Research
Medical Properties Trust (MPW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Key Factors to Impact Medical Properties' (MPW) Q2 Earnings
by Zacks Equity Research
Stellar revenues from transactions and improving fundamentals of its tenants are likely to have aided Medical Properties' (MPW) Q2 performance.
Medical Properties (MPW) Q1 FFO Match Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 0.00% and 3.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: Williams-Sonoma, Southern Copper, Qorvo, PennyMac Financial Services and Medical Properties Trust
by Zacks Equity Research
Zacks.com featured highlights include: Williams-Sonoma, Southern Copper, Qorvo, PennyMac Financial Services and Medical Properties Trust
5 Top-Ranked Stocks With Solid Sales Growth Worth Betting on
by Swayta Shah
Sales growth is an indicator of a company's future earnings performance. Let's check out Williams-Sonoma (WSM), Southern Copper (SCCO), Qorvo (QRVO), PennyMac Financial (PFSI) & Medical Properties Trust (MPW) that may see robust sales growth.
Medical Properties (MPW) Meets Q4 FFO Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 0.00% and 1.02%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Medical Properties (MPW) Taps Equity Market to Fund Buyout
by Zacks Equity Research
Medical Properties (MPW) prices offering of 32 million shares at $20.05 per share. Net proceeds will be used to fund the buyout of a portfolio of behavioral healthcare real estate assets in the U.K.
Medical Properties (MPW) Prices $1.3B Senior Notes, To Repay Debt
by Zacks Equity Research
Proceeds from Medical Properties' (MPW) $1.3-billion senior notes offering will be used to repay debt obligations due in 2024. This is likely to enhance its financial flexibility.
Medical Properties (MPW) Surpasses Q3 FFO and Revenue Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 5.13% and 4.14%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Medical Properties (MPW) Meets Q2 FFO Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 0.00% and -5.81%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Medical Properties (MPW) June Rent Collections Total 96%
by Zacks Equity Research
Medical Properties' (MPW) June rent collections are in line with the previous two months. It finishes a lease agreement with Circle Health and begins to recognize additional straight-line rent on Jun 16.
Sector ETFs & Stocks to Explode as Fed Remains Dovish
by Sweta Killa
Low rates are a boon for high-yield sectors such as utilities and real estate as well as the dividend paying securities.
Medical Properties (MPW) Offers Update on May Rent Collection
by Zacks Equity Research
Medical Properties (MPW) collects 96% of May rent and loan payments, consistent with April collections. The trend, even in unprecedented times, demonstrates strength in the company's tenant roster.
Medical Properties (MPW) Q1 FFO and Revenues Miss Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of -7.50% and -5.89%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Apple, Amazon, Medical Properties Trust, Amcor and Global Medical REIT
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Amazon, Medical Properties Trust, Amcor and Global Medical REIT
3 Cheap & Safe High-Yield Dividend Stocks Under $20 to Buy Right Now
by Benjamin Rains
Today we dive into 3 cheap stocks trading under $20 a share that also pay a dividend. Plus, the stocks we focused on are relatively immune from the current coronavirus economic downturn...